Walleye Trading’s Haemonetics HAE Stock Holding History

Walleye Trading’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,600	Closed	-$128K	–	4358
2025 Q4	$128K	Buy	+1,600	New	+$108K	﹤0.01%	3630
2025 Q2	–	Sell	-2,100	Closed	-$133K	–	4412
2025 Q1	$133K	Buy	+2,100	New	+$143K	﹤0.01%	3267
2023 Q2	–	Sell	-5,300	Closed	-$439K	–	4884
2023 Q1	$439K	Buy	+5,300	New	+$429K	﹤0.01%	2904
2022 Q1	–	Sell	-1,500	Closed	-$80K	–	5534
2021 Q4	$80K	Buy	1,500 +1,000	+200%	+$60.9K	﹤0.01%	4493
2021 Q3	$35K	Sell	500 -21,700	-98%	-$1.37M	﹤0.01%	4736
2021 Q2	$1.48M	Buy	+22,200	New	+$1.57M	0.01%	1768

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Trading's HAE Position: Q1 2026 in Review

Walleye Trading sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 6,822 shares — an estimated $547K sold.

Walleye Trading first reported a position in HAE in Q2 2015 and held it in 13 quarters. The position peaked at $722K in Q2 2022. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Walleye Trading reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
Walleye Trading sold 6,822 Haemonetics shares in Q1 2026, an estimated $547K.
Walleye Trading first reported a position in Haemonetics in Q2 2015 and held it in 13 quarters.
Walleye Trading's Haemonetics position peaked at $722K in Q2 2022.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.